For patients with colorectal cancer, the long-term use of statins is associated with better clinical outcomes

Digestive Diseases and Sciences

Volumn 54, Issue 6, 2009, Pages 1307-1311

  Siddiqui, Ali A ^a   Nazario, Hector ^a,b   Mahgoub, Amar ^a,b   Patel, Mahir ^b   Cipher, Daisha ^c   Spechler, Stuart J ^a,b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Dallas Veterans Affairs Research Corporation   (United States)

Author keywords

3 Hydroxy 3 methyl glutaryl coenzyme A inhibitors; Colorectal cancer; Metastasis

Indexed keywords

ATORVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CASE CONTROL STUDY; CHI SQUARE TEST; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; LONGEVITY; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO;

EID: 67349239967     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0790-8     Document Type: Article

References (19)

1. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96
2. WW Wong J Dimitroulakos MD Minden LZ Penn 2002 HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 508 519 (Pubitemid 34460459)
3. M Jakobisiak J Golab 2003 Potential antitumor effects of statins Int J Oncol 23 1055 1069 Review
4. M Carlberg A Dricu H Blegen M Wang M Hjertman P Zickert A Hoog O Larsson 1996 Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth J Biol Chem 271 17453 17462 (Pubitemid 26244311)
5. T Narisawa M Morotomi Y Fukaura M Hasebe M Ito R Aizawa 1996 Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats Jpn J Cancer Res 87 798 804 (Pubitemid 26335806)
6. B Agarwal CV Rao S Bhendwal WR Ramey H Shirin BS Reddy PR Holt 1999 Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac Gastroenterology 117 838 847 (Pubitemid 29468226)
7. JN Poynter SB Gruber PD Higgins R Almog JD Bonner HS Rennert M Low JK Greenson G Rennert 2005 Statins and the risk of colorectal cancer N Engl J Med 352 2184 2192 (Pubitemid 40727085)
8. T Kusama M Mukai T Iwasaki M Tatsuta Y Matsumoto H Akedo H Nakamura 2001 Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors Cancer Res 61 4885 4891 (Pubitemid 32691906)
9. SL Zielinski 2005 Following positive epidemiologic studies, statins to enter clinical trials for cancer prevention J Natl Cancer Inst 97 1172 1173 (Pubitemid 41258217)
10. TP Bhuket PD Higgins 2006 Drug insight: statins and gastrointestinal cancer Nat Clin Pract Gastroenterol Hepatol 3 552 562 (Pubitemid 44489588)
11. IK Wang SY Lin-Shiau JK Lin 2000 Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation Oncology 59 245 254
12. HJ Park D Kong L Iruela-Arispe U Begley D Tang JB Galper 2002 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA Circ Res 91 143 150
13. K Hindler CS Cleeland E Rivera CD Collard 2006 The role of statins in cancer therapy Oncologist 11 306 315
14. SA Broitman J Wilkinson S Cerda SK Branch 1996 Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo Adv Exp Med Biol 401 111 130 (Pubitemid 26326195)
15. MV Swamy I Cooma BS Reddy CV Rao 2002 Lamin B caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens Int J Oncol 20 753 759
16. PF Coogan J Smith L Rosenberg 2007 Statin use and risk of colorectal cancer J Natl Cancer Inst 99 32 40
17. S Bonovas K Filioussi CS Flordellis NM Sitaras 2007 Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients J Clin Oncol 25 3462 3468 (Pubitemid 47310884)
18. JA Kaye H Jick 2004 Statin use and cancer risk in the general practice research database Br J Cancer 90 635 637 (Pubitemid 38297203)
19. MR Graaf AB Beiderbeck AC Egberts DJ Richel HJ Guchelaar 2004 The risk of cancer in users of statins J Clin Oncol 22 2388 2394 (Pubitemid 41115396)